Total Payments
$6,929
2024 Payments
$1,088
Companies
30
Transactions
280
Medicare Patients
1,007
Medicare Billing
$212,617
Payment Breakdown by Category
Food & Beverage$6,363 (91.8%)
Education$564.44 (8.1%)
Gifts$1.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,363 | 253 | 91.8% |
| Education | $564.44 | 26 | 8.1% |
| Gift | $1.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1,151 | 46 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $714.54 | 30 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $691.44 | 31 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $594.84 | 19 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $511.88 | 8 | $0 (2022) |
| Amgen Inc. | $482.55 | 21 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $454.29 | 18 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $347.81 | 10 | $0 (2024) |
| Horizon Pharma plc | $305.71 | 8 | $0 (2018) |
| GlaxoSmithKline, LLC. | $194.72 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,088 | 57 | Amgen Inc. ($363.97) |
| 2023 | $968.15 | 47 | Aurinia Pharma U.S., Inc. ($292.32) |
| 2022 | $767.20 | 28 | Horizon Therapeutics plc ($389.40) |
| 2021 | $1,030 | 46 | AstraZeneca Pharmaceuticals LP ($472.59) |
| 2020 | $608.50 | 19 | Horizon Therapeutics plc ($262.71) |
| 2019 | $644.44 | 24 | Mallinckrodt Enterprises LLC ($190.06) |
| 2018 | $739.61 | 25 | Horizon Pharma plc ($294.38) |
| 2017 | $1,083 | 34 | Fresenius USA Marketing, Inc. ($420.87) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $52.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.20 | General |
| 10/01/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/16/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: NEPHROLOGY | ||||||
| 06/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 202 | 408 | $97,103 | $44,195 |
| 2022 | 6 | 184 | 404 | $70,755 | $32,429 |
| 2021 | 7 | 248 | 585 | $115,242 | $56,664 |
| 2020 | 11 | 373 | 878 | $157,174 | $79,329 |
Total Patients
1,007
Total Services
2,275
Medicare Billing
$212,617
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 210 | $39,900 | $17,246 | 43.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 11 | 34 | $18,088 | $8,242 | 45.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 56 | $8,512 | $5,131 | 60.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 25 | $11,000 | $4,719 | 42.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 13 | 18 | $7,902 | $3,836 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,952 | $1,476 | 37.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,245 | $1,469 | 45.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 21 | $2,226 | $1,218 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $2,278 | $857.90 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 202 | $38,380 | $16,431 | 42.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 128 | $19,456 | $9,936 | 51.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 16 | $4,720 | $2,460 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $3,886 | $1,683 | 43.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,458 | $1,517 | 43.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 15 | $855.00 | $401.95 | 47.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 264 | $49,165 | $23,264 | 47.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 49 | $25,081 | $13,007 | 51.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 30 | 139 | $21,145 | $11,360 | 53.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 22 | $6,490 | $3,343 | 51.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $5,165 | $2,338 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 43 | $5,505 | $2,221 | 40.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 47 | $2,691 | $1,130 | 42.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 21 | 95 | $40,122 | $21,219 | 52.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 49 | 229 | $35,470 | $19,114 | 53.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 210 | $33,369 | $13,974 | 41.9% |
About Dr. Karl Schwarze, M.D
Dr. Karl Schwarze, M.D is a Specialist healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053426932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karl Schwarze, M.D has received a total of $6,929 in payments from pharmaceutical and medical device companies, with $1,088 received in 2024. These payments were reported across 280 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,363).
As a Medicare-enrolled provider, Schwarze has provided services to 1,007 Medicare beneficiaries, totaling 2,275 services with total Medicare billing of $212,617. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Akron, OH
- Active Since 08/20/2006
- Last Updated 06/04/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1053426932
Products in Payments
- KRYSTEXXA (Biological) $1,501
- ACTHAR (Biological) $1,131
- JYNARQUE (Drug) $590.83
- LOKELMA (Drug) $478.30
- LUPKYNIS (Drug) $347.81
- KRYSTEXXA (Drug) $305.71
- Not Product Related (Medical Supply) $222.92
- Critline - Monitors (Device) $197.95
- Auryxia (Drug) $195.99
- PURIFIED CORTROPHIN GEL (Drug) $148.93
- SAMSCA (Drug) $123.71
- BPV-Lutonix (Device) $122.53
- Parsabiv (Biological) $118.58
- BENLYSTA (Biological) $104.29
- INJECTAFER (Drug) $103.27
- Kerendia (Drug) $98.84
- Velphoro (Drug) $91.01
- IBSRELA (Drug) $88.57
- FARXIGA (Drug) $74.39
- Crysvita (Drug) $72.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Akron
Dr. Timothy Pittinger, M.d, M.D
Specialist — Payments: $86,464
Specialist $86,464
Dr. Nazar Kalivoshko, Md, MD
Specialist — Payments: $34,450
Specialist $34,450
Preti Chaturvedi, M.d, M.D
Specialist — Payments: $12,158
Specialist $12,158
Dr. Michael Waickman, M.d, M.D
Specialist — Payments: $10,431
Specialist $10,431
Dr. Thomas Repko, M.d, M.D
Specialist — Payments: $3,743
Specialist $3,743
Dr. Atul Goswami, M.d, M.D
Specialist — Payments: $2,918
Specialist $2,918